Pregnancy and birth under maintenance treatment with diamorphine (heroin): A case report

European Addiction Research

Volumn 14, Issue 2, 2008, Pages 113-114

  Hartwig, Christina ^a   Haasen, Christian ^a   Reimer, Jens ^a   Garbe, Werner ^b   Lichtermann, Dirk ^c   Wuellenweber, Linde ^d   Dilg, Christoph ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ST MARIEN HOSPITAL   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d Ambulante Suchthilfe CW/DW   (Germany)

Author keywords

Birth; Diamorphine; Pregnancy

Indexed keywords

BENZODIAZEPINE; CANNABIS; COCAINE; DIAMORPHINE; METHADONE; NALOXONE; NICOTINE; PHENOBARBITAL; PSYCHEDELIC AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHILDBIRTH; DISEASE COURSE; DRUG DEPENDENCE; DRUG DOSE REDUCTION; FEMALE; HUMAN; MAINTENANCE THERAPY; MALE; NEWBORN; PATIENT COMPLIANCE; PERSONALITY DISORDER; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

ADULT; FEMALE; HEROIN; HUMANS; INFANT, NEWBORN; MALE; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; SUBSTANCE-RELATED DISORDERS;

EID: 40549086275     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113726     Document Type: Article

References (12)

1. Fajemirokun-Odudeyi O, Sinha C, Tutty S, Pairaudeau P, Armstrong D, Phillips T, Lindow SW: Pregnancy outcome in women who use opiates. Eur J Obstet Gynecol Reprod Biol 2006;126:170-175.
2. Messinger DS, Bauer CR, Das A, Seifer R, Lester BM, Lagasse LL, et al: The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics 2004;113:1677-1685.
3. Ludlow JP, Evans SF, Hulse G: Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Aust NZ J Obstet Gynaecol 2004;44:302-306.
4. Fischer G: Treatment of opioid dependence in pregnant women. Addiction 2000;95:1141-1144.
5. Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A: Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 2001;358:1417-1423.
6. van den Brink W, Hendriks VM, Blanken P, Koeter MW, van Zwieten BJ, van Ree JM: Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 2003;327:310.
7. Hartnoll RL, Mitcheson MC, Battersby A, Brown G, Ellis M, Fleming P, Hedley N: Evaluation of heroin maintenance in controlled trial. Arch Gen Psychiatry 1980;37:877-884.
8. Haasen C, Verthein U, Degwitz P, Berger J, Krausz M, Naber D: Heroin-assisted treatment for opioid dependence: a randomised, controlled trial. Br J Psychiatry 2007;191:55-62.
9. March JC, Oviedo-Joekes E, Perea-Milla E, Carrasco F: Controlled trial of prescribed heroin in the treatment of opioid addiction. J Subst Abuse Treat 2006;31:203-211.
10. Wilson GS, Desmond MM, Wait RB: Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: health, developmental, and social implications. J Pediatr 1981;98:716-722.
11. Doberczak TM, Kandall SR, Willets I: Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 1991;118:933-937.
12. Kashiwagi M, Arlettaz R, Lauper U, Zimmermann R, Hebisch G: Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies. Acta Obstet Gynecol Scand 2005;84:140-144.